Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy Smith

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycinVlatka Matic, Klaudia Kosowska, Bulent Bozdogan, et al.
Vaccine|June 4, 2023
Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373Katia Alves, Joyce S Plested, Shirley Galbiati, et al.
The New England Journal of Medicine|February 3, 2023
Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373Katia Alves, Joyce S Plested, Shirley Galbiati, et al.
Clinical Rehabilitation|December 26, 2025
Perspectives of early mobility in the cardiac surgery intensive care unit: an interpretive description studyEmily K Phillips, Amy Abegglen, Jacqueline L Hay, et al.
Anaesthesia, Critical Care & Pain Medicine|October 1, 2025
Scoping review of early mobility in the intensive care unit following cardiac surgeryEmily K Phillips, Jacqueline L Hay, Caroline Monnin, et al.
Journal of Critical Care|April 9, 2026
Assessing the quality of consent discussions in intensive care unit research: A scoping review of outcome measuresHeather K O'Grady, Bianca Marcella, Prey Patel, et al.
The New England Journal of Medicine|June 30, 2021
Safety and Efficacy of NVX-CoV2373 Covid-19 VaccinePaul T Heath, Eva P Galiza, David N Baxter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2022
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled TrialPaul T Heath, Eva P Galiza, David Neil Baxter, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Antimicrobial Agents and Chemotherapy|October 27, 2004
Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycinVlatka Matic, Klaudia Kosowska, Bulent Bozdogan, et al.
Vaccine|June 4, 2023
Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373Katia Alves, Joyce S Plested, Shirley Galbiati, et al.
The New England Journal of Medicine|February 3, 2023
Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373Katia Alves, Joyce S Plested, Shirley Galbiati, et al.
Clinical Rehabilitation|December 26, 2025
Perspectives of early mobility in the cardiac surgery intensive care unit: an interpretive description studyEmily K Phillips, Amy Abegglen, Jacqueline L Hay, et al.
Anaesthesia, Critical Care & Pain Medicine|October 1, 2025
Scoping review of early mobility in the intensive care unit following cardiac surgeryEmily K Phillips, Jacqueline L Hay, Caroline Monnin, et al.
Journal of Critical Care|April 9, 2026
Assessing the quality of consent discussions in intensive care unit research: A scoping review of outcome measuresHeather K O'Grady, Bianca Marcella, Prey Patel, et al.
The New England Journal of Medicine|June 30, 2021
Safety and Efficacy of NVX-CoV2373 Covid-19 VaccinePaul T Heath, Eva P Galiza, David N Baxter, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2022
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled TrialPaul T Heath, Eva P Galiza, David Neil Baxter, et al.
Pageof 4